1138245-21-2 Usage
Uses
Used in Pharmaceutical Industry:
Mirogabalin besylate is used as a therapeutic agent for the treatment of nerve pain.
It is particularly effective in managing pain caused by diabetic peripheral neuropathy and postherpetic neuralgia due to its mechanism of action that involves binding to calcium channels in the central nervous system, thus reducing the release of neurotransmitters responsible for pain signal transmission.
Common side effects associated with the use of mirogabalin besylate may include dizziness, drowsiness, and headache. It is crucial for patients to adhere to the dosing instructions provided by healthcare professionals and to promptly report any severe or persistent side effects to ensure safe and effective treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 1138245-21-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,8,2,4 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1138245-21:
(9*1)+(8*1)+(7*3)+(6*8)+(5*2)+(4*4)+(3*5)+(2*2)+(1*1)=132
132 % 10 = 2
So 1138245-21-2 is a valid CAS Registry Number.
1138245-21-2Relevant academic research and scientific papers
METHOD FOR PRODUCING OPTICALLY ACTIVE BICYCLIC -AMINO ACID DERIVATIVE
-
, (2015/05/26)
An object of the present invention is to provide an optically active bicyclic γ-amino acid derivative in a high purity. The object can be attained by a mixture of compounds represented by the general formulas (I) and (I'), or a method for producing a compound represented by the general formula (VII) or a salt thereof via the compound (I): wherein R1 and R2 each represent a C1-6 alkyl group or the like; and R3 represents a cyano group or the like,
BICYCLIC -AMINO ACID DERIVATIVE
-
Page/Page column 52, (2010/06/17)
It is intended to provide a bicyclic γ-amino acid derivative having excellent activity as an α2δ ligand. The present invention provides a compound represented by the general formula (I): wherein R1, R2, R2', R4, R5, R6, R7, R8, and R8' are a hydrogen atom or the like; and R3 is a hydrogen atom, a halogen atom, a C1-C6 alkyl group, or the like.
